Gilbert, P B <br/><br/>
Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.  [electronic resource] 

 -  Vaccine  Jun 2003 
 - 2933-47 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/s0264-410x(03)00158-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--adverse effects<br/>Adolescent<br/>Adult<br/>Canarypox virus--genetics<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Double-Blind Method<br/>Female<br/>HIV-1--immunology<br/>Humans<br/>Male<br/>Middle Aged<br/>National Institutes of Health (U.S.)<br/>Randomized Controlled Trials as Topic<br/>Salmonella--genetics<br/>Time<br/>United States<br/>Vaccines, Subunit--adverse effects<br/>Vaccines, Synthetic--adverse effects<br/>Vaccinia virus--genetics